Free Trial

Tema Etfs LLC Grows Stock Position in CME Group Inc. $CME

CME Group logo with Finance background

Key Points

  • Tema Etfs LLC increased its stake in CME Group by 146.2%, acquiring an additional 3,800 shares, bringing its total holdings to 6,400 shares valued at approximately $1.7 million.
  • CME Group reported earnings of $2.96 per share for the last quarter, exceeding the consensus estimate by $0.05, with revenues also surpassing expectations at $1.69 billion.
  • The company announced a quarterly dividend of $1.25 per share, set to be paid on September 25th, representing an annualized dividend yield of 1.9%.
  • Interested in CME Group? Here are five stocks we like better.

Tema Etfs LLC boosted its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 146.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 6,400 shares of the financial services provider's stock after buying an additional 3,800 shares during the period. Tema Etfs LLC's holdings in CME Group were worth $1,698,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wayfinding Financial LLC purchased a new stake in CME Group during the 1st quarter valued at $25,000. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Golden State Wealth Management LLC grew its position in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares during the last quarter. Alpine Bank Wealth Management bought a new position in CME Group in the 1st quarter valued at $32,000. Finally, Financial Gravity Asset Management Inc. bought a new position in CME Group in the 1st quarter valued at $32,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Stock Down 0.1%

Shares of CME traded down $0.26 during midday trading on Monday, reaching $266.51. 1,562,708 shares of the stock were exchanged, compared to its average volume of 1,859,420. CME Group Inc. has a 52 week low of $207.75 and a 52 week high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company's 50 day moving average is $275.64 and its two-hundred day moving average is $269.50. The company has a market capitalization of $96.04 billion, a P/E ratio of 25.80, a PEG ratio of 4.82 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the company earned $2.56 EPS. The business's revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Insider Activity at CME Group

In related news, Director Charles P. Carey sold 500 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director owned 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have commented on CME. Oppenheimer upped their price objective on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research report on Thursday, July 24th. UBS Group reaffirmed a "neutral" rating and issued a $305.00 price objective on shares of CME Group in a research report on Thursday, July 24th. Citigroup upped their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Finally, Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $261.93.

Check Out Our Latest Research Report on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines